上脊髄抗侵害受容
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Enhanced GABAergic synaptic transmission at VLPAG neurons and potent modulation by oxycodone in a bone cancer pain model.
- Takasu K1, Ogawa K, Nakamura A, Kanbara T, Ono H, Tomii T, Morioka Y, Hasegawa M, Shibasaki M, Mori T, Suzuki T, Sakaguchi G.
- British journal of pharmacology.Br J Pharmacol.2015 Apr;172(8):2148-64. doi: 10.1111/bph.13039. Epub 2015 Feb 10.
- BACKGROUND AND PURPOSE: We demonstrated previously that oxycodone has potent antinociceptive effects at supraspinal sites. In this study, we investigated changes in neuronal function and antinociceptive mechanisms of oxycodone at ventrolateral periaqueductal gray (VLPAG) neurons, which are a major s
- PMID 25521524
- The activation of supraspinal GPR40/FFA1 receptor signalling regulates the descending pain control system.
- Nakamoto K1, Nishinaka T, Sato N, Aizawa F, Yamashita T, Mankura M, Koyama Y, Kasuya F, Tokuyama S.
- British journal of pharmacology.Br J Pharmacol.2015 Mar;172(5):1250-62. doi: 10.1111/bph.13003. Epub 2015 Jan 12.
- BACKGROUND AND PURPOSE: The ω-3 polyunsaturated fatty acids exert antinociceptive effects in inflammatory and neuropathic pain; however, the underlying mechanisms remain unclear. Docosahexaenoic acid-induced antinociception may be mediated by the orphan GPR40, now identified as the free fatty acid
- PMID 25362997
- Antinociceptive effect of intracerebroventricular administration of glycine transporter-2 inhibitor ALX1393 in rat models of inflammatory and neuropathic pain.
- Takahashi Y1, Hara K2, Haranishi Y1, Terada T1, Obara G1, Sata T1.
- Pharmacology, biochemistry, and behavior.Pharmacol Biochem Behav.2015 Mar;130:46-52. doi: 10.1016/j.pbb.2015.01.001. Epub 2015 Jan 9.
- Glycinergic transmission has an important role in regulating nociception in the spinal cord. The glycine transporter-2 (GlyT2) is localized at presynaptic terminals of glycinergic neurons and eliminates glycine from the synaptic cleft to terminate glycinergic transmission. Systemic and intrathecal a
- PMID 25579325
Japanese Journal
- Nicotine Effects and the Endogenous Opioid System
- Kishioka Shiroh,Kiguchi Norikazu,Kobayashi Yuka,Saika Fumihiro
- Journal of Pharmacological Sciences 125(2), 117-124, 2014
- … Systemic administration of NIC elicits the release of endogenous opioids (endorphins, enkephalins, and dynorphins) in the supraspinal cord. … The endogenous opioid system participates in NIC-induced antinociception, but not HPA axis activation. … Moreover, NIC-induced antinociception is mediated by α4β2 and α7 nAChRs, while NIC-induced HPA axis activation is mediated by α4β2, not α7, suggesting that the effects of NIC on the endogenous opioid system are mediated by α7, not α4β2. …
- NAID 130004438636
- ドコサヘキサエン酸による抗侵害作用の発現機序の解明
- 西中 崇,松本 健吾,中本 賀寿夫 [他],安保 明博,万倉 三正,小山 豊,徳山 尚吾
- YAKUGAKU ZASSHI 133(5), 493-499, 2013
- … Here, we performed elucidation of mechanisms underlying DHA-induced antinociception. … Furthermore, the pretreatment of anti β-endorphin antiserum inhibited DHA-induced antinociception. … These findings suggest that DHA-induced antinociception via β-endorphin release may be mediated through GPR40 signaling in the supraspinal area. …
- NAID 130003361941
- <Originals>Gabapentin produces antinociceptive effects on the spinal cord with simultaneous activation of descending facilitation in spinal nerve-ligated rats
- Yabuta Koichi,Takasugi Yoshihiro,Tabuchi Masaki,Mizuguchi Nobuyuki,Koga Yoshihisa,Higashino Hideaki,Nakao Shinichi
- Acta Medica Kinki University 36(1), 7-14, 2011-06
- … Although both spinal and supraspinal neuronal mechanisms participate in the antinociceptive effects of gabapentin, the supraspinal contribution to the effects of gabapentin at the spinal level remains unclear. … The results of this study indicate that gabapentin causes both apparent antinociception at the spinal level and simultaneousdescending facilitation in neuropathic pain conditions. …
- NAID 120003291651
Related Links
- Activating the spinal D2 receptor or blocking the supraspinal D2 receptor produces antinociception. D1 receptor might be not directly involved in the antinociception. l-THP (as a D2 antagonist) as well as spiperone
- These findings support the suggestion that there exists a pathway that ascends from the spinal cord to a supraspinal site that tonically inhibits antinociception mediated by supraspinal opioids. When activity in this ascending pathway is suppressed (e.g., by i.t. opioids or local anesthetics or by spinal cord transection), antinociception ...
- Supraspinal antinociception by intracerebroventricular administration of P2 purinoceptor agonists in rats Masato Fukui, Azusa Takishita, Nannan Zhang, Takayuki Nakagawa, Masabumi Minami, and Masamichi Satoh
★リンクテーブル★
[★]
- 英
- supraspinal antinociception
[★]
- 関
- antinociceptive
[★]